Sage Journals: Discover world-class research

Abstract

Systemic lupus erythematosus (SLE) is a multisystem disorder which appears to be influenced by genetic make-up. In this study we determine allele frequency and genotype distribution of TNFa polymorphisms in two populations of SLE patients (with and without neuropsychiatric manifestations) in order to determine whether the rare allele (TNF2) confers susceptibility for neuropsychiatric disease in SLE. Patients with SLE were retrospectively reviewed to determine presence (n = 17) or absence (n = 47) of documented neuropsychiatric manifestations attributable to SLE. The DNA from these patients was extracted from peripheral blood mononuclear cells, and PCR amplification, NcoI enzyme digestion and 10% polyacrylamide gel electrophoresis were performed to define the different TNFa alleles. Two alleles were demonstrated, TNF1 (wild-type) and TNF2 (rare type), with three possible genotypes, TNF1,1, TNF1,2 and TNF2,2. A frequency of 24% was found for the TNF2 patients with neuropsychiatricinvolvement and was not statistically different to a frequency of 28% found in SLE patients without neuropsychiatric manifestations. The TNF-2 allele does not confer susceptibility for neuropsychiatric manifestations in SLE patients.

Keywords

tumour necrosis factor systemic lupus erythematosus central nervous system polymorphism genetics

Get full access to this article

View all access options for this article.

References

edospasov SA et al. Tandem arrangement of genes coding for tumour necrosis factor (TNF-a) and lymphotoxin (TNF-b) in the human genome . Cold Spring Harbour Symp Quant Biol 1986; 51: 611–624 .

pies T et al. Genes for tumour necrosis factor a and b are linked to the human major histocompatibility complex . Proc Natl Acad Sci USA 1986; 83: 8699–8702 .

ilson AG , di Giovane FS , Blakemore AIF , Duff GW . Single base polymorphism in the human tumour necrosis factor (TNF alpha) gene detectable by NcoI restriction of PCR product . Hum Mol Genet 1992; 1: 353-353 .

ilson AG et al. An allelic polymorphism within the human tumour necrosis factor a promoter region is strongly associated with HLA A1, B8, and DR3 alleles . J Exp Med 1993; 177: 557–560 .

ilson AG et al. Effects of a tumour necrosis factor (TNFa) promoter base transition on transcriptional activity . Br J Rheum 1994; 33(Suppl 1): 89-89 .

chwartz BD . The major histocompatibility complex and disease susceptibility. In: Wyngaarden JB , Smith LH Jr and Bennett JC (eds). Cecil Textbook of Medicine. WB Saunders: Philadelphia , 1992, pp 1470–1479.

ofman FM , Hinton DR , Johnson K , Merrill JE . Tumour necrosis factor identified in multiple sclerosis brain . J Exp Med 1989; 170: 607–612 .

elmaj K , Raine CS , Cannella B , Brosnan CF . Identification of lymphotoxin and tumour necrosis factor in multiple sclerosis lesions . J Clin Invest 1991; 87: 949–954 .

harief MK , Hentges R . Association between TNF and disease progression in patients with multiple sclerosis . New Engl J Med 1991; 325: 467–472 .

10.

Tyor WR et al. Cytokine expression in the brain during the acquired immunodeficiency syndrome . Ann Neurol 1992; 31: 349–360 .

11.

Probert L et al. Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system—specific expression of tumour necrosis factor a . Proc Natl Acad Sci USA 1995; 92: 11294–11298 .

12.

McGuire W , Hill AVS , Allsop CEM , Greenwood BM , Kwiatkowski D . Variation in the TNF-a promotor region associated with susceptibility to malaria . Nature 1994; 371: 508–511 .

13.

Grau GE et al. TNF and disease severity in children with Falciparum malaria . New Engl J Med 1989; 320: 1586–1591 .

14.

Kern P et al. Elevated TNFa and IL6 serum levels as markers for complicated Plasmodium falciparum malaria . Am J Med 1989; 83: 139–143 .

15.

Kwiatkowski D et al. TNF concentration in fatal cerebral, non-fatal cerebral and uncomplicated Plasmodium falciparum malaria . Lancet 1990; 336: 1201–1204 .

16.

Berendt AR , Simmons DL , Tansey J , Newbold CI , Marsh K . Intercellular adhesion molecule-I is an endothelial cell adhesion receptor for Plasmodium falciparum . Nature 1989; 341: 57–59 .

17.

Grau GE , Piquet P-F , Vassalli P , Lambert PH . Involvement of tumour necrosis factor and other immune-mediated vascular pathology . Int Arch Allergy Appl Immunol 1989; 88: 34–39 .

18.

Maury CPJ , Teppo A-M . Tumour necrosis factor in the serum of patients with systemic lupus erythematosus . Arthrit Rheum 1989; 32: 146–150 .

19.

Wilson AG et al. A genetic association between systemic lupus erythematsus and tumour necrosis factor alpha . Eur J Immunol 1994; 24: 191–195 .

20.

Danis VA et al. Increased frequency of the uncommon allele of a tumour necrosis factor alpha polymorphism in rheumatoid arthritis and SLE . Dis Markers 1994; 12: 127–133 .

21.

Tan EM et al. The 1982 revised criteria for the classification of SLE . Arthrit Rheum 1982; 25: 1271–1277 .

22.

Wyman AR , White R . A highly polymorphic locus in human DNA . Proc Natl Acad Sci USA 1980; 77: 6754–6758 .

23.

Singer J , Denburg JA . Diagnostic criteria for neuropsychiatric systemic lupus erthematosus: the results of a consensus meeting . J Rheumatol 1990; 17: 1397–1402 .

24.

West SG , Emlen W , Wener MH , Kotzin BL . Neuropsychiatric lupus erythmatosus: a 10 year prospective study on the value of diagnostic tests . Am J Med 1995; 99: 153–163 .

25.

Tracey KJ , Cerami A . Tumour necrosis factor: an updated review of its biology . Crit Care Med 1993; 21: 5415–5420 .

26.

Tomita Y et al. Restriction fragment length polymorphism (RFLP) analysis in the TNF genes of patients with systemic lupus erythematosus (SLE) . Clin Exp Rheumatol 1993; 11: 553–556 .

27.

Rudwaleit M et al. Interethnic differences in the association of tumor necrosis factor promoter polymorphisms with systemic lupus erythematosus . J Rheumatol 1996; 23: 1725–1728 .

28.

Grau GE et al. Tumour necrosis factor. (Cachectin) as an essential mediator in murine cerebral malaria . Science 1987; 237: 1210–1212 .

29.

Selmaj K , CS Raine . Tumour necrosis factor mediates myelin and oligodendrocyte damage in vitro . Ann Neurol 1988; 23: 339–345

30.

West SG . Neuropsychiatric lupus . Rheum Dis Clin N Am 1994; 20: 129–158

31.

Bresnihan B et al. The neuropsychiatric disorder in systemic lupus erthematosus: evidence for both vascular and immune mechanisms . Ann Rheum Dis 1979; 38: 301–306 .

32.

Bertolaccini ML et al. Plasma tumor necrosis factor a levels and the 7238 *A promoter polymorphism in patients with antiphospholipid syndrome . Thromb Haemost 2001; 85: 198–203 .

33.

Feinglass EJ et al. Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of disease . Medicine 1976; 55: 323–339 .

34.

West SG . Lupus and the nervous system . Curr Opin Rheumatol 1996; 8: 408–414 .

35.

Boumpas DT et al. Cyclophosphamide for severe neuropsychiatric lupus . Q J Med 1991; 296: 975–984 .

36.

Abel T , Gladman D , Urowitz MB . Neuropsychiatric lupus . J Rheumatol 1980; 7: 325–333 .

37.

Jarek MJ , West SG , Baker MR , Rak KM . Magnetic resonance imaging in systemic lupus erthematosus patients without a history of neuropsychiatric lupus erythematosus . Arthrit Rheum 1994; 37: 1609–1613 .

38.

Stoppe G et al. Positron emission tomography in neuropsychiatric lupus erythematosus . Neurology 1990; 40: 304–308 .

39.

Utset TO et al. Depressive symptoms in patients with systemic lupus erythematosus: association with central nervous system lupus and Sjogren's syndrome . J Rheumatol 1994; 21: 2039–2045 .

Relationship of tumour necrosis factor alpha gene polymorphisms and neuropsychiatric lupus

Abstract

Keywords

Get full access to this article

References